Those pesky social media keyboard warriors again.
3 years post re-listing and the company has yet to have any commercial success.
Costco - no more orders?
Triploids - shouldnt we get triple the news?
Vitahemp\T12 - change the brand name and focus on direct to consumer - for higher profit margins. Grassroots, couldnt giveaway 5 packs of product, is this indicative of the market penetration?
500 tonnes of hemp seed - drought wiped it out - not material to announce to shareholders.
Olivias Choice - whoops we dont have permission to import the ingredients
Hemp hulling Co - only hulling facility in australia, still goes broke - not material to inform shareholders at the time.
Pharmocann - pharmowhat now?
Pet Food range - we dont talk about the pet food range
Epco Food Co (Vietnam) - Covid?
Canntab - Cant import them anymore.. Legal claim from Medcan - not material to inform shareholders?
MS Study at WSU - Any news on those clinical trials?
So in all fairness, can we forget about the re-listing debacle of 3yrs ago, which we know was caused by legitimate issues that ASIC felt they needed to ask further information of the company, and concentrate on what the company is doing to rectify the the Canntab situation, the Medcan lawsuit, sell the Grass Roots range and sell some Fuss Pot, at a commercially viable price.
- Forums
- ASX - By Stock
- CGB
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-66
-
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online